A detailed history of Hellman Jordan Management CO Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Hellman Jordan Management CO Inc holds 6,073 shares of MRNA stock, worth $704,164. This represents 1.85% of its overall portfolio holdings.

Number of Shares
6,073
Previous 5,557 9.29%
Holding current value
$704,164
Previous $657,000 66.06%
% of portfolio
1.85%
Previous 1.14%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 20, 2023

BUY
$118.38 - $210.04 $61,084 - $108,380
516 Added 9.29%
6,073 $1.09 Million
Q3 2022

Oct 13, 2022

BUY
$118.07 - $194.18 $656,114 - $1.08 Million
5,557 New
5,557 $657,000
Q4 2021

Jan 26, 2022

SELL
$225.82 - $368.51 $348,666 - $568,979
-1,544 Closed
0 $0
Q3 2021

Oct 26, 2021

SELL
$221.9 - $484.47 $256,516 - $560,047
-1,156 Reduced 42.81%
1,544 $594,000
Q2 2021

Jul 21, 2021

SELL
$129.91 - $234.98 $9,223 - $16,683
-71 Reduced 2.56%
2,700 $634,000
Q1 2021

May 06, 2021

BUY
$109.18 - $185.98 $302,537 - $515,350
2,771 New
2,771 $363,000
Q4 2020

Jan 29, 2021

SELL
$65.74 - $169.86 $3.39 Million - $8.77 Million
-51,632 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$54.34 - $94.85 $1.45 Million - $2.52 Million
-26,600 Reduced 34.0%
51,632 $3.65 Million
Q2 2020

Jul 21, 2020

SELL
$29.67 - $80.0 $687,869 - $1.85 Million
-23,184 Reduced 22.86%
78,232 $5.02 Million
Q1 2020

May 28, 2020

SELL
$17.78 - $31.58 $1.16 Million - $2.06 Million
-65,344 Reduced 39.18%
101,416 $3.04 Million
Q4 2019

Feb 21, 2020

BUY
$13.93 - $21.28 $21,326 - $32,579
1,531 Added 0.93%
166,760 $3.26 Million
Q3 2019

Dec 20, 2019

BUY
$12.26 - $18.07 $37,086 - $54,661
3,025 Added 1.86%
165,229 $2.63 Million
Q2 2019

Aug 19, 2019

BUY
$13.7 - $28.34 $301,400 - $623,480
22,000 Added 15.69%
162,204 $2.38 Million
Q1 2019

Jun 11, 2019

BUY
$14.45 - $23.7 $2.03 Million - $3.32 Million
140,204 New
140,204 $2.85 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $45.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Hellman Jordan Management CO Inc Portfolio

Follow Hellman Jordan Management CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hellman Jordan Management CO Inc , based on Form 13F filings with the SEC.

News

Stay updated on Hellman Jordan Management CO Inc with notifications on news.